Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00361452Phase 4Terminated
Phase 4, randomised, double-blind trial of epinephrine in respiratory syncytial virus bronchiolitis (2 arms), sponsored by Rambam Health Care Campus. Primary endpoints: Respiratory Clinical Score at 30 months and Computerized Quantification of Wheezing and Crackles at 30 months. Started Dec 2000; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00361452.